Drug recall D-0140-2020
Product
Pioglitazone Hydrochloride Tablets USP 15 mg, 30 count bottles, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ, Manufactured by: Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, India NDC 33342-054-07
Reason for recall
Superpotent
Lots and codes
Lot # BPF901A, exp. date 12/2021
Recall details
- Recalling firm
- Macleods Pharma Usa Inc, Plainsboro, NJ
- Quantity
- 31,968 bottles
- Distribution
- Product was shipped to 8 distributors who may have further distributed the product.
- Type
- Voluntary: Firm initiated
- Recall initiated
- September 23, 2019
- Terminated
- February 23, 2021
Related products
- Pioglitazone – drug information
- NDC 33342-054 Pioglitazone · Pioglitazone Hydrochloride 15 mg/1 · Macleods Pharmaceuticals Limited
- NDC 33342-056 Pioglitazone · Pioglitazone Hydrochloride 45 mg/1 · Macleods Pharmaceuticals Limited
- NDC 33342-055 Pioglitazone · Pioglitazone Hydrochloride 30 mg/1 · Macleods Pharmaceuticals Limited